NKD2 and colorectal carcinoma: More recently, Wu et al. have documented the prognostic value of several WNT signaling pathway molecules in colorectal cancer (CRC), including NKD2, and the inhibition of NKD2 could inhibit the tumor cell growth of CRC [31].